Skip to content
healthcare.dev

Dapagliflozin

NDC 70710-1381, Dapagliflozin, tablet, from Zydus Pharmaceuticals USA Inc..

Product NDC
70710-1381
Status
Listed
Labeler
Zydus Pharmaceuticals USA Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211582
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1381 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DAPAGLIFLOZIN10 mg/1

Pharmacologic classes

Sodium-Glucose Cotransporter 2 Inhibitor [EPC]; Sodium-Glucose Transporter 2 Inhibitors [MoA]

Package NDCNDC-11Package
70710-1381-37071013810330 TABLET in 1 BOTTLE (70710-1381-3)
70710-1381-97071013810990 TABLET in 1 BOTTLE (70710-1381-9)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/17586ec6-0104-4b08-ad87-12a837568d6c
  • NADAC price for package 70710138103

    GET /v1/drugs/nadac/70710138103

Use it

Look up 70710-1381 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1381 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70710-1381. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.